In a newly legal, fast-growing industry, the trajectory of some young companies can be a wild trip.

MedBox’s big plans to produce and sell medical marijuana dispensary machines gave the company a market capitalization of more than $2 billion in late 2012, but two years later, news of a U.S. Securities and Exchange Commission investigation and the company’s subsequent restatement of its 2013-2014 financial results helped drive the share price into penny stock territory.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]